WHWK
NASDAQ · Biotechnology
Whitehawk Therapeutics Inc
$2.76
+0.05 (+1.85%)
Open$2.71
Previous Close$2.71
Day High$2.86
Day Low$2.63
52W High$21.14
52W Low$13.43
Volume—
Avg Volume226.3K
Market Cap131.02M
P/E Ratio59.40
EPS$0.28
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+527.2% upside
Current
$2.76
$2.76
Target
$17.31
$17.31
$14.24
$17.31 avg
$28.90
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.02M | 8.91M | 7.24M |
| Net Income | 2.49M | 2.41M | 1.66M |
| Profit Margin | 27.6% | 27.1% | 22.9% |
| EBITDA | 4.05M | 4.31M | 3.06M |
| Free Cash Flow | 1.13M | 1.46M | 1.28M |
| Rev Growth | -0.9% | +22.0% | +4.1% |
| Debt/Equity | 0.51 | 0.54 | 0.68 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |